Prophylaxis of the spontaneous interruption of pregnancy (fetal miscarriage) in the antiphospholipid syndrome;Profilaxis de la interrupcion espontanea del embarazo (perdidas fetales) en el sindrome antifosfolipido

Revista Espanola de Reumatologia

Volumn 24, Issue 3, 1997, Pages 95-100

  Mola, Emilio Martín ^a   Campillo, Jaime Fernández ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; INTERLEUKIN 3; LOW MOLECULAR WEIGHT HEPARIN;

ABORTION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL TRIAL; FEMALE; FETUS; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 12644280827     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Hughes GRV, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
2. Harris N. Antiphospholipid syndrome En. Klippel JH, Dieppe PA, editores. Rheumatology. Mosby-Year Book Europe Limited, 1994; 1-6.
3. Harris EN, Gharavi AE, Loizou S, Derve G, Chan JK, Patel BM et al Cross-reeactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16: 1-6
4. Greisman SG, Thayaparan RS, Godwin TA, Lockshin MD. Occlusive vasculopathy in systemic lupus erythematosus. association with anti-cardiolipin antibody Arch Intern Med 1991; 151: 389-392.
5. Bick RL, Baker WF. Antiphospholipid and thrombosis syndromes Semin Thromb Hemost 1994, 20. 3-15.
6. Scott JR Spontaneous abortion En. Danforth's, editor. Obstetrics and gynecology Filadelfia: J B. Lippincott Company, 1990; 209-220.
7. Laurell AB, Nilsson IM Hypergammaglobulinemia circulating anticoagulant, and biologic false-positive Wasserman reaction. J Lab Clin Med 1995; 49: 694-707.
8. Nilsson IM, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant («antithromboplasrin»). Acta Med Scand 1995; 197. 153-159.
9. Hughes GRV. The antiphospholipid syndrome: Ten years on. Lancet 1993; 342: 341-344
10. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North 1993; 19: 235-242.
11. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North 1994; 20: 45-59.
12. Martínez Brotons F Síndrome del anticuerpo antifosfolípido y trombosis. Rev Clin Esp 1994; 194: 417-425.
13. Harris EN, Chan JKA, Asherson RA, Aber VR, Gharavi AE, Hughes GRV Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986, 146: 2.153-2.156.
14. Parke AL, Wilson D, Maier D, The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34. 1.231-1.235.
15. Petri M, Howard D, Repke J, Goldman DW. The Hopktins lupus pregnancy center. 1987; 1991 update. Am J Reprod Immunol 1992, 28. 188-191.
16. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541-545.
17. Out HJ, Kooijman CD, Bruise HW, Derksen R Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies Eur J Obstet Gynecol Reprod Biol 1991; 41: 179-186.
18. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Costner B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369-373.
19. Harris En, Spinnato JA. Should anticardiolipin test be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991. 165 1 272-1 277.
20. Petri M Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North 1994; 20: 87-118
21. Brach DW, Silver RM, Blackwell JL, Reading JC, Scott JR Outcome of treated pregnancies in women with antiphospholipid syndrome, an update of the Utah experience. Obstet Gynecol 1992; 80. 614-620.
22. Lockshin MD, Druzin ML, Gamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439-443.
23. Silveira LH, Hubble CL, Jara L, Saway S, Martínez-Osuna P, Seleznick MJ. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med 1992; 93: 403-411.
24. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhorf MG, Ragin A. Comparative trial of prednisone plus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients Am J Obstet Gynecol 1993; 169: 1.411-1.417
25. Many A, Pauzner R, Carp H, Langevitz P, Martinowitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol 1992; 28: 216-218
26. Cowchock FS, Reece EA, Balaban D, Branch DW, Pouffe L. Repeated fetal losses associated with antiphospholipid antibodies a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1.318-1 323
27. Balasch J, Carmona F, López-Soto A, Font J, Creus M, Fábregas F Low dose-aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993; 8: 2.234-2.239.
28. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalumian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75. 630-634.
29. Pauzner R, Dolitzky M, Langevitz P, Livneh A, Many T. Treatment of APLA syndrome in pregnancy with low molecular weight heparin combined with aspirin. Arthritis Rheum 1994; 37: 325
30. Kaaja R, Julkunen H, Ammala P, Palosuo T, Kurdi P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993, 72: 63-66.
31. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161. 1.271-1.272.
32. Fishman P, Falach-Vaknine E, Zigelman R, Bakimer R, Sredni B, Djaldetti M et al. Prevention of fetal loss in experimental antiphospholipid syndrome in vivo in vivo administration of recombinant interleukin-3. J Clin Invest 1993; 91: 1.834-1.837.
33. Tomer Y, Blank M, Schoenfeld Y. Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies Arthritis Rheum 1994; 37: 1 236-1.244.
34. Kersake S, Morton KE, Versi E, Buchanan NM, Khamashta M, Baguley et al. Early Doppler studies in lupus pregnancy. Am J Reprod Immunol 1992; 28: 172-175.